BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6201451)

  • 1. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
    Brunner F; Zini R; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of non-steroidal anti-inflammatory drugs on the binding kinetics of dansylsarcosine to human serum albumin. Stereoselectivity, steric and inductive effects.
    Keita Y; Wörner W; Veile G; Woodcock BG; Fuhr U
    Arzneimittelforschung; 1996 Feb; 46(2):164-8. PubMed ID: 8720306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
    Ozer I; Tacal O
    Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of erythromycin base to human plasma proteins.
    Prandota J; Tillement JP; d'Athis P; Campos H; Barre J
    J Int Med Res; 1980; 8 Suppl 2():1-8. PubMed ID: 7429002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and pharmacokinetic studies with fenbufen in man.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):728-35. PubMed ID: 7192124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of homopyrimidazole derivatives with biopolymers. I. Binding of MZ 144, a new potent analgesic to human serum albumin.
    Szekerke M; Horváth M
    Arzneimittelforschung; 1975 Jul; 25(7):1016-21. PubMed ID: 241355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood binding of selezen (imidazole salicylate) in man.
    Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of tiaprofenic acid to human sera and isolated serum proteins.
    Nilsen OG; Storhaug A; Dale O
    Arzneimittelforschung; 1985; 35(6):984-7. PubMed ID: 4026926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of furosemide to albumin isolated from human fetal and adult serum.
    Viani A; Cappiello M; Silvestri D; Pacifici GM
    Dev Pharmacol Ther; 1991; 16(1):33-40. PubMed ID: 1879250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.